Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Krueger, J. Kunde, R. Marre, N. Suttorp, T. Welte (Aachen, Hennigsdorf, Ulm, Berlin, Hannover, Germany). Procalcitonin and neopterin in community-acquired pneumonia – correlation with microbial aetiology, severity and mortality. Eur Respir J 2009; 34: Suppl. 53, 2364

Member's Comments

No comment yet.

Related content which might interest you: Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Serum procalcitonin (PCT) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP) Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007 Correlation of procalcitonin and CRP in community-acquired pneumonia with CRB-65 score and prognosis – results from the German competence network CAPNETZ Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 Systemic cytokine levels in community-acquired pneumonia and their association with disease severity Source: Eur Respir J 2002; 20: 990-995 Year: 2002 The correlation between D-dimer and pneumonia severity in H1N1 patients Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010 Value of hypoalbuminemia as a sign of severity of community-acquired pneumonia Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007 Prognostic value of procalcitonin in community-acquired pneumonia Source: Eur Respir J 2011; 37: 384 Year: 2011 Serum procalcitonin and community-acquired pneumonia in childhood Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005 Hyponatremia in community-acquired pneumonia due to increased vasopressin secretion – impact on mortality Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Usefulness of C-reactive protein and procalcitonin in predicting mortality in community-acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 D-dimer elevation is associated with severity of community-acquired pneumonia according to CURB-65 and PSI Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 C-reactive protein as severity biomarker in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 545s Year: 2005 Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia Source: Eur Respir J 2008; 32: 726-732 Year: 2008 Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia Source: Eur Respir J 2008; 31: 356-362 Year: 2008 Could procalcitonin (PCT) be a marker of effectiveness of antibiotic treatment (ABT) in pregnant with not severe community-acquired pneumonia (CAP)? Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015 Association of CRP values with clinico-radiological appearance in adults with community-acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 374s Year: 2006 Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 groups at risk Source: Eur Respir J 2007; 30: Suppl. 51, 481s Year: 2007 Community-acquired pneumonia trough enterobacteriaceae and p. aeruginosa: diagnosis, incidence, and predictors. The German CAPNETZ Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa Year: 2009 Procalcitonin as etiological marker of severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013